Nutranomics Valuation
| NNRX Stock | USD 0.0001 0.00 0.00% |
Nutranomics seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Nutranomics from analyzing the firm fundamentals such as Return On Asset of -1.72, shares outstanding of 580.67 M, and Price To Sales of 0.01 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Nutranomics' price fluctuation is out of control at this time. Calculation of the real value of Nutranomics is based on 3 months time horizon. Increasing Nutranomics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nutranomics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nutranomics Pink Sheet. However, Nutranomics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 6.3E-5 | Hype 1.0E-4 | Naive 1.11E-4 |
The intrinsic value of Nutranomics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nutranomics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nutranomics helps investors to forecast how Nutranomics pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nutranomics more accurately as focusing exclusively on Nutranomics' fundamentals will not take into account other important factors: Nutranomics Total Value Analysis
Nutranomics is now projected to have valuation of 1.23 M with market capitalization of 29.03 K, debt of 3.45 M, and cash on hands of 34. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nutranomics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.23 M | 29.03 K | 3.45 M | 34 |
Nutranomics Asset Utilization
One of the ways to look at asset utilization of Nutranomics is to check how much profit was generated for every dollar of assets it reports. Nutranomics secures a negative usage of assets of -1.72 %, losing $0.0172 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Nutranomics shows how discouraging it operates for each dollar spent on its assets.Nutranomics Ownership Allocation
Nutranomics maintains a total of 580.67 Million outstanding shares. Nutranomics secures 8.64 % of its outstanding shares held by insiders and 0.0 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Nutranomics Profitability Analysis
Net Loss for the year was (950.79 K) with loss before overhead, payroll, taxes, and interest of (407).About Nutranomics Valuation
Our relative valuation model uses a comparative analysis of Nutranomics. We calculate exposure to Nutranomics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nutranomics's related companies.Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. The company was founded in 1995 and is headquartered in Salt Lake City, Utah. Nutranomics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct Nutranomics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nutranomics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nutranomics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nutranomics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nutranomics' revenue streams: Identify Nutranomics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nutranomics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nutranomics' growth potential: Evaluate Nutranomics' management, business model, and growth potential.
- Determine Nutranomics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nutranomics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Nutranomics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | -12.4 M | |
| Quarterly Revenue Growth Y O Y | -0.362 |
Additional Tools for Nutranomics Pink Sheet Analysis
When running Nutranomics' price analysis, check to measure Nutranomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutranomics is operating at the current time. Most of Nutranomics' value examination focuses on studying past and present price action to predict the probability of Nutranomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutranomics' price. Additionally, you may evaluate how the addition of Nutranomics to your portfolios can decrease your overall portfolio volatility.